NCT00204776已完成2 期
A Phase II Trial of Capecitabine and Oxaliplatin in Metastatic Breast Cancer
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 37
- 试验地点
- 2
- 主要终点
- Overall response rate
研究概览
简要总结
Both capecitabine and oxaliplatin have single agent activity in breast cancer. The combination has improved activity in other solid tumors. This study seeks to assess the activity of the combination in breast cancer.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •preserved organ function
- •good performance status
- •no more than one prior therapy
- •no active brain metastasis
排除标准
- •No prior capecitabine or oxaliplatin
- •no con-current therapy
结局指标
主要结局
Overall response rate
次要结局
- Toxicity
- Time to progression
研究者
研究点 (2)
Loading locations...
相似试验
终止
2 期
A Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular CancerHepatocellular CancerLiver CancerNCT03026803City of Hope Medical Center4
已完成
2 期
Oxaliplatin and Capecitabine in Patients With Unresectable CholangiocarcinomaCancer of the GallbladderCancer of the Biliary TractNCT00338988M.D. Anderson Cancer Center44
已完成
2 期
Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal CancerColorectal CancerNCT00220116Royal Marsden NHS Foundation Trust172
终止
2 期
Title XELOX FOR SALIVARY GLAND CANCERSHead and Neck CancerNCT00101075Dana-Farber Cancer Institute9
已完成
2 期
Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck MalignanciesHead or Neck CancerNCT00266279University of Louisville17